1. Home
  2. WST vs GIB Comparison

WST vs GIB Comparison

Compare WST & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • GIB
  • Stock Information
  • Founded
  • WST 1923
  • GIB 1976
  • Country
  • WST United States
  • GIB Canada
  • Employees
  • WST N/A
  • GIB N/A
  • Industry
  • WST Medical/Dental Instruments
  • GIB Professional Services
  • Sector
  • WST Health Care
  • GIB Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • GIB Nasdaq
  • Market Cap
  • WST 15.6B
  • GIB 24.2B
  • IPO Year
  • WST N/A
  • GIB N/A
  • Fundamental
  • Price
  • WST $221.49
  • GIB $105.83
  • Analyst Decision
  • WST Buy
  • GIB Buy
  • Analyst Count
  • WST 7
  • GIB 4
  • Target Price
  • WST $331.67
  • GIB $156.75
  • AVG Volume (30 Days)
  • WST 686.8K
  • GIB 235.9K
  • Earning Date
  • WST 07-24-2025
  • GIB 07-30-2025
  • Dividend Yield
  • WST 0.38%
  • GIB 0.30%
  • EPS Growth
  • WST N/A
  • GIB 8.72
  • EPS
  • WST 6.37
  • GIB 5.30
  • Revenue
  • WST $2,895,800,000.00
  • GIB $10,533,984,064.00
  • Revenue This Year
  • WST $3.38
  • GIB $11.12
  • Revenue Next Year
  • WST $5.85
  • GIB $4.86
  • P/E Ratio
  • WST $34.89
  • GIB $19.95
  • Revenue Growth
  • WST N/A
  • GIB 4.60
  • 52 Week Low
  • WST $187.43
  • GIB $92.85
  • 52 Week High
  • WST $352.33
  • GIB $122.79
  • Technical
  • Relative Strength Index (RSI)
  • WST 50.87
  • GIB 43.90
  • Support Level
  • WST $215.67
  • GIB $102.35
  • Resistance Level
  • WST $221.74
  • GIB $105.00
  • Average True Range (ATR)
  • WST 4.90
  • GIB 1.54
  • MACD
  • WST -0.42
  • GIB -0.42
  • Stochastic Oscillator
  • WST 31.68
  • GIB 32.12

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.

Share on Social Networks: